Inhibitory effect of the nonpeptide angiotensin II receptor antagonist losartan and its active metabolite, E-3174, on cAMP phosphodiesterase: additional action of the antagonists

This publication has 16 references indexed in Scilit:

• Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans.
  British Journal of Clinical Pharmacology, 1993
• Nonpeptide angiotensin II receptor antagonists
  Trends in Pharmacological Sciences, 1991
• Inhibition of bovine brain calmodulin-dependent cGMP phosphodiesterase by peptide and non-peptide angiotensin receptor ligands
  Biochemical and Biophysical Research Communications, 1991
• A structurally novel inhibitor of cGMP phosphodiesterase with vasodilator activity
  Biochemical Pharmacology, 1990
• Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X.
  Hypertension, 1990
• Nonpeptide angiotensin II receptor antagonists. IV. EXP6155 and EXP6803.
  Hypertension, 1989
• Pertussis toxin abolishes angiotensin II-induced phosphoinositide hydrolysis and prostaglandin synthesis in rat renal mesangial cells
  Biochemical Journal, 1986
• Renin-angiotensin system: biochemistry and mechanisms of action.
  Physiological Reviews, 1977
• The importance of phospholipase-A2 in prostaglandin biosynthesis
  Biochemical Pharmacology, 1976
• Properties of Cyclic 3',5'-Nucleotide Phosphodiesterase from Rat Brain^*
  Biochemistry, 1967